Does Rallies show MGTX 10-K and 10-Q filings?

Rallies organizes MGTX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.

Is MGTX research on Rallies investment advice?

No. Rallies provides research, data, and educational context for MGTX. It does not provide personalized investment advice.

MGTX (MeiraGTx Holdings plc Ordinary Shares) Stock Analysis - SEC Filings

MeiraGTx Holdings plc Ordinary Shares (MGTX) is a publicly traded Healthcare sector company. As of May 21, 2026, MGTX trades at $9.41 with a market cap of $870.53M and a P/E ratio of -6.41. MGTX moved +4.71% today. Year to date, MGTX is +26.89%; over the trailing twelve months it is +74.18%. Its 52-week range spans $3.97 to $11.85. Analyst consensus is strong buy with an average price target of $24.00. Rallies surfaces MGTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find MGTX SEC filings?

Rallies organizes MGTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

MGTX Key Metrics

Key financial metrics for MGTX
Metric	Value
Price	$9.41
Market Cap	$870.53M
P/E Ratio	-6.41
EPS	$-1.48
Dividend Yield	0.00%
52-Week High	$11.85
52-Week Low	$3.97
Volume	4
Avg Volume	0
Revenue (TTM)	$79.76M
Net Income	$-120.53M
Gross Margin	0.00%

Latest MGTX News

MeiraGTx Reports FDA Breakthrough, Raises $100M, Acquires Bota-vec for $25M — May 14, 2026
MeiraGTx Prices $100M Offering at $9 to Fund Gene Therapy Launches — Apr 16, 2026
MeiraGTx Shows 3-Year Saliva Flow Gains and Durable Xerostomia Relief — Apr 16, 2026
Breakthrough Status for Xerostomia Therapy; $200M AI JV and Lilly Ocular Deal — Mar 26, 2026

Recent MGTX Insider Trades

Forbes Alexandria sold 62.00K (~$568.54K) on May 19, 2026.
Giroux Richard sold 56.00K (~$572.32K) on Apr 21, 2026.
Naylor Stuart sold 27.66K (~$258.91K) on Apr 7, 2026.

MGTX Analyst Consensus

6 analysts cover MGTX: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $24.00.

Common questions about MGTX

Where can I find MGTX SEC filings?: Rallies organizes MGTX SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show MGTX 10-K and 10-Q filings?: Rallies organizes MGTX SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is MGTX research on Rallies investment advice?: No. Rallies provides research, data, and educational context for MGTX. It does not provide personalized investment advice.